Home › Funds › Commodore Capital LP › ANRO

Commodore Capital LP position in ANRO

ALTO NEUROSCIENCE INC COM SHS · Health Care

Commodore Capital LP reported holding 2,723,196 shares of ANRO (ALTO NEUROSCIENCE INC COM SHS) in its Q2 2026 13F filing — a position valued at US$71.9M, representing 4.28% of its reported portfolio and ranking #8 among its reported holdings. Commodore Capital LP has disclosed ANRO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)2.72M sh
Reported value held$71.87M
Portfolio Weight4.28%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's ANRO position evolved

Commodore Capital LP first disclosed a stake in ANRO in Q4 2025 at 1,823,196 shares (US$32.5M). The position peaked in Q2 2026 at 2,723,196 shares, worth US$71.9M. Across 3 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,723,196 shares valued at US$71.9M. Notable position changes include a 49% increase in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.82M $32.45M New
Q1 2026 2.72M $61.22M Add
Q2 2026 2.72M $71.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC COM SHS) is a Health Care company. 58 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), PERCEPTIVE ADVISORS LLC (US$42.5M), Spruce Street Capital LP (US$35.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Commodore Capital LP held ANRO?

Commodore Capital LP has disclosed ANRO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Commodore Capital LP's current position in ANRO?

As of Q2 2026, Commodore Capital LP holds 2.72M shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $71.87M, representing 4.28% of its reported portfolio and ranking #8.

Has Commodore Capital LP been buying or selling ANRO?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in ANRO. The position peaked in Q2 2026 at 2.72M shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, PERCEPTIVE ADVISORS LLC, Spruce Street Capital LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.